Pulmonary Hypertension Trial, Recruiting NCT07529834 Sponsor: Foundation University Islamabad Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07529834
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been medically diagnosed with Stage 1 high blood pressure (systolic reading of 140–159 mmHg, diastolic reading of 90–99 mmHg) or Stage 2 high blood pressure (systolic reading of 160 mmHg or higher, diastolic reading of 100 mmHg or higher), as classified by JNC 8 Guidelines, and have been referred by a GP, specialist, or heart doctor from specific hospitals or clinics in Rawalpindi or Islamabad
  • People who have been taking blood pressure medication for at least 3 months before the study begins
  • People aged between 20 and 55 years old
  • Both men and women are eligible to participate
  • People who are willing to take part in an exercise program, have not participated in any regular exercise program in the past 6 months, are able to give their informed consent, and have been cleared as safe to exercise through a standard health screening questionnaire called the PAR-Q+

Who may not be able to join:

  • People with very high blood pressure classified as Stage 3 or above (systolic reading of 180 mmHg or higher, or diastolic reading of 110 mmHg or higher), or those experiencing a hypertensive crisis, as defined by JNC 8 Guidelines
  • People with severe knee problems or other bone or joint conditions that would limit their ability to exercise
  • People whose blood pressure is not currently controlled or stable
  • People who have had abdominal, bone and joint, or spinal surgery that could affect their ability to do core or breathing exercises
  • People with neurological or psychiatric (brain, nerve, or mental health) conditions
  • People with uncontrolled heart conditions, such as irregular heartbeat or a recent heart attack
  • Women who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03295200871

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Foundation University Islamabad
Registry
ClinicalTrials.gov
Start date
12 January 2026
Est. completion
15 May 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Blood Pressure (SBP and DBP); Chest Expansion; Pulmonary Function Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov